Synthesis and evaluation of some new 4-aminopyridine derivatives as a potent antiamnesic and cognition enhancing drugs
- 520 Downloads
4-Aminopyridine (4AP) potentiates acetylcholine (ACh) release by blocking potassium channel in axon terminal and can be used in the treatment of Alzheimer’s type of dementia and cognitive disorder. It is reported that ACh is well related with memory and learning. On the basis of these fact, we decided to synthesis and evaluate some new Schiff bases of 4AP (SBAPs) for their putative cognition enhancing, antiamnesic, and anticholinesterase activity. The synthesized and purified SBAPs were characterized by elemental analysis, UV, FTIR, 1H-, and 13C-NMR. SBAPs facilitated the learning on elevated plus maze model and they also significantly reversed the scopolamine-induced amnesia on the same model. The effect of SBAPs on learning and memory was qualitatively similar to standard nootropic drug piracetam used. The SBAPs were found to inhibit acetylcholinesterase enzyme significantly in specific brain regions prefrontal cortex, hippocampus, and hypothalamus. Thus, SBAPs derivatives showed cognitive and antiamnesic activities in the model tested and these effects may probably be due to their anticholinesterase activity.
Keywords4-Aminopyridine Nootropic Antiamnesic Anticholinesterase Elevated plus maze
The authors gratefully acknowledge the University Grants Commission (UGC), New Delhi, India for the financial support to Mr. Saurabh K. Sinha (Grant no. R/Dev./IX-Sch./(SRF-JRF) Pharm./15402).
- Belluti F, Bartolini M, Bottegoni G, Bisi A, Cavalli A, Andrisano V, Rampa A (2011) Benzophenone-based derivatives: a novel series of potent and selective dual inhibitors of acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation. Eur J Med Chem 46:1682–1693CrossRefPubMedGoogle Scholar
- Giacobini E (2001) Is anti-cholinesterase therapy of Alzheimer’s disease delaying progression? Aging (Milano) 13:247–254Google Scholar
- Solari A, Uitdehaag BMJ, Giuliani G, Pucci E, Taus C (2001) Aminopyridines for symptomatic treatment in multiple sclerosis. Cochrane Database Syst Rev (4): CD001330Google Scholar
- Taylor P (2001) Anticholinesterase agents. In: Hardman JG, Limbird LE (eds) The pharmacological basis of therapeutics, 10th edn. McGraw-Hill, New York, p 175Google Scholar